Content continues after advertisement

Intranasal Naloxone Administration in Dogs

Travis Lanaux, DVM, DACVECC, University of Florida

Sign in to Print/View PDF

In the Literature

Wahler BM, Lerche P, Pereira CHR, et al. Pharmacokinetics and pharmacodynamics of intranasal and intravenous naloxone hydrochloride administration in healthy dogs. Am J Vet Res. 2019;80(7):696-701.


FROM THE PAGE …

The growing crisis of the abuse of illicit and prescription opioids in humans has led to accidental exposures in pets and working dogs.1-4 In humans, a commercial intranasal naloxone hydrochloride atomizer is available to treat opioid overdoses and may be purchased without a prescription.5 There is a growing interest in the use of such atomizers in veterinary patients, particularly for emergency stabilization prior to transporting a patient to a veterinary facility for care.3,4

This study compared IV naloxone with intranasal naloxone delivered by a commercially available atomizer in healthy dogs. Time to reach peak plasma levels, maximum concentration, and naloxone half-life were measured and calculated. The intranasal route rapidly achieved clinically useful plasma levels in healthy medium-sized dogs. Naloxone was detectable in plasma 2.3 ± 1.4 minutes after intranasal administration; mean time to maximum concentration in plasma was 22.5 ± 8.2 minutes. Naloxone half-life was similar for both routes of administration (IV, 37 ± 6.7 minutes; intranasal, 47.4 ± 6.7 minutes). It is unclear if nasal conformation (eg, brachycephaly, dolichocephaly) affects intranasal absorption.

Reported adverse effects of naloxone include excitability, vomiting, and tachycardia; however, there were no notable changes in behavior, heart rate, or respiratory rate following naloxone administration by either route in this study.


… TO YOUR PATIENTS

Key pearls to put into practice:

1

Naloxone has a shorter half-life as compared with many opiates.5-8 Therefore, it should be stressed to pet owners that, in the event of an accidental opioid overdose, veterinary attention should be sought immediately even if naloxone has been administered and the pet has responded well, as the pet will likely require further care.

2

The commercially available naloxone atomizer delivers a single 4-mg dose. The relative body size will likely affect the dose achieved in plasma. Smaller dogs should theoretically achieve higher plasma levels, whereas large- or giant-breed dogs may achieve lower plasma levels.

References

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast

Listen as host Beckie Mossor, RVT, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 05/08/2018) Terms of Use (Updated 05/08/2018)